| MolName | 2-morpholin-4-yl-N-[(6Z,12Z)-2-[(2-morpholin-4-ylacetyl)amino]-6,12-diphenylbenzo[c][1,5]benzodiazocin-8-yl]acetamide |
| MolecularFormula | C38H38N6O4 |
| Smiles | O=C(CN1CCOCC1)NC1=C/C2=C(\c3ccccc3)/N=C(/C=CC(NC(CN3CCOCC3)=O)=C3)\C3=C(\c3ccccc3)/N=C2/C=C1 |
| InChI | InChI=1S/C38H38N6O4/c45-35(25-43-15-19-47-20-16-43)39-29-11-13-33-31(23-29)37(27-7-3-1-4-8-27)41-34-14-12-30(40-36(46)26-44-17-21-48-22-18-44)24-32(34)38(42-33)28-9-5-2-6-10-28/h1-14,23-24H,15-22,25-26H2,(H,39,45)(H,40,46) |
| InChIK | YKUKYBLHSCZVGM-UHFFFAOYSA-N |
| TotalMolweight | 642.758 |
| Molweight | 642.758 |
| MonoisotopicMass | 642.295454 |
| CLogP | 2.1804 |
| CLogS | -3.624 |
| H Acceptors | 10 |
| H Donors | 2 |
| TotalSurfaceArea | 496.34 |
| Relative PSA | 0.1997 |
| PolarSurfaceArea | 107.86 |
| Druglikeness | 4.2413 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.47917 |
| Fragments | 1 |
| Non HAtoms | 48 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 8 |
| Rings Closures | 7 |
| Small Rings | 6 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 14 |
| Symmetricatoms | 28 |
| Amides | 2 |
| Amines | 2 |
| AlkylAmines | 2 |
| BasicNitrogens | 4 |
| StereoCon |
Click to Load Molecule:
1 - 2-morpholin-4-yl-N-[(6Z,12Z)-2-[(2-morpholin-4-ylacetyl)amino]-6,12-diphenylbenzo[c][1,5]benzodiazocin-8-yl]acetamide | 2 - 2-morpholin-4-yl-N-[(6Z,12Z)-2-[(2-morpholin-4-ylacetyl)amino]-6,12-diphenylbenzo[c][1,5]benzodiazocin-8-yl]acetamide